Back to Trades
Sell4
Kiniksa Pharmaceuticals International, plc
KNSA
Total Value
$751.2K
Net $364.0K sold
Sales
$364.0K
1 transaction
Company Information
- Company Name
- Kiniksa Pharmaceuticals International, plc
- Ticker Symbol
- KNSA
- CIK
- 0001730430
Insider Information
- Name
- Patel Sanj K
- Role
- Insider
Filing Details
- Filing Date
- Apr 8, 2026
- Transaction Date
- Apr 6, 2026
- Accession Number
- 0001532218-26-000004
- Form Type
- 4
- Net Trading Amount
- -$364.0K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Apr 6, 2026 | Class A Ordinary Share | 7,278 | $10.36 | Exercise | $75.4K |
| Apr 6, 2026 | Class A Ordinary Share | 7,278 | $50.01 | Sale | $364.0K |
| Apr 7, 2026 | Class A Ordinary Share | 9,991 | — | Exercise | — |
| Apr 7, 2026 | Class A Ordinary Share | 4,831 | $48.94 | Tax Withholding | $236.4K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Apr 6, 2026 | Derivative | 7,278 | $10.36 | Exercise | $75.4K |
| Apr 7, 2026 | Derivative | 9,991 | — | Exercise | — |
Footnotes
- (F1)This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on October 31, 2025.
- (F2)This transaction was executed in multiple trades through a broker-dealer at prices ranging between $50.005 and $50.03. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
- (F3)Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.
- (F4)The option is fully vested and exercisable.
- (F5)The RSUs vest over a four-year period, with 25% of the RSs vesting on the yearly anniversary of the grant date, April 7, 2022.